Showing 1 - 10 of 523
While the COVID-19 pandemic had a large and asymmetric impact on firms, many countries quickly enacted massive business rescue programs which are specifically targeted to smaller firms. Little is known about the effects of such policies on business entry and exit, factor reallocation, and...
Persistent link: https://www.econbiz.de/10013166369
it enhances the long-run resource productivity. Our result contradicts the green-paradox conjecture that technical …
Persistent link: https://www.econbiz.de/10009769158
agglomeration economies. Using detailed data on EU transfers, we infer the local effects of different transfer types on productivity …
Persistent link: https://www.econbiz.de/10011752504
policies unilaterally, innovation is fostered, at the margin, only by the R&D subsidy. The patent box tax rate is instead …
Persistent link: https://www.econbiz.de/10012304080
monopolistic market structures. We concentrate our analysis on three particularly common forms of subsidies: (i) a per-unit subsidy …, (ii) an ad valorem subsidy, and (iii) an "inversely related" subsidy, which increases as the price of the target good … on a pass-through analysis - and a cost‑effectiveness criterion. Overall, the ad valorem subsidy always yields the …
Persistent link: https://www.econbiz.de/10015427367
, policymakers have devised new subsidy schemes such as the "bridge electricity price" (BEP). To analyze this, we develop a model …, where the principal introduces a subsidy program to prevent the agent from exiting and facilitate green investments, which … would end the agent's reliance on the subsidy. We demonstrate that, while successfully mitigating deindustrialization, the …
Persistent link: https://www.econbiz.de/10015434312
SMPEs with positive taxable income increased investment, interest expense and productivity. SMPEs in taxable losses did not …
Persistent link: https://www.econbiz.de/10012668013
pharmaceutical R&D expenditure, drug prices, aggregate productivity, and income. The analysis suggests that both an increase in the …-sharing and entry barriers in the pharmaceutical sector also affect aggregate productivity and wage rates. -- aggregate … productivity ; cost-sharing ; entry deregulation ; health insurance ; pharmaceutical innovation …
Persistent link: https://www.econbiz.de/10009124148
We study the impact of research collaborations in coauthorship networks on research output and how optimal funding can maximize it. Through the links in the collaboration network, researchers create spillovers not only to their direct coauthors but also to researchers indirectly linked to them....
Persistent link: https://www.econbiz.de/10011925969
certain conditions, the optimal pollution tax is positive; otherwise, the tax reverts to a subsidy. Comparing mixed and …
Persistent link: https://www.econbiz.de/10011800081